Biomotion Financial Statements From 2010 to 2026

SLXN Stock   1.77  0.03  1.67%   
Biomotion Sciences' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Biomotion Sciences' valuation are provided below:
Market Capitalization
5.6 M
Earnings Share
349.09
We have found one hundred eighteen available fundamental signals for Biomotion Sciences Ordinary, which can be analyzed and compared to other ratios and to its rivals. Self-guided Investors are advised to validate Biomotion Sciences' prevailing fundamentals against the trend between 2010 and 2026 to make sure the company can sustain itself down the road. As of the 4th of February 2026, Enterprise Value is likely to drop to about 3.5 B
Check Biomotion Sciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Biomotion Sciences' main balance sheet or income statement drivers, such as Other Operating Expenses of 15.2 M, Total Operating Expenses of 15.2 M or Tax Provision of 17.6 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. Biomotion financial statements analysis is a perfect complement when working with Biomotion Sciences Valuation or Volatility modules.
  
Build AI portfolio with Biomotion Stock
Check out the analysis of Biomotion Sciences Correlation against competitors.

Biomotion Sciences Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Current Liabilities4.3 M4.1 M996.1 K
Slightly volatile
Net Tangible Assets929.2 K626.4 K869.9 K
Slightly volatile
Accounts Payable1.1 M1.1 M349.6 K
Slightly volatile
Net Receivables100 K80.1 K101.8 K
Slightly volatile
Other Current Assets1.3 M1.2 M447.6 K
Slightly volatile
Total Current AssetsM2.6 M1.7 M
Slightly volatile
Property Plant Equipment8.8 K10.3 K8.7 K
Slightly volatile
Total Assets2.4 M2.6 M8.2 M
Pretty Stable
Other Current Liabilities1.1 M1.6 M460.8 K
Slightly volatile
Cash1.3 M1.4 MM
Slightly volatile
Non Current Assets Total524.1 K551.7 KM
Pretty Stable
Non Currrent Assets Other38.1 K47.7 K63.7 K
Slightly volatile
Cash And Short Term Investments1.3 M1.4 MM
Slightly volatile
Common Stock Shares Outstanding9.1 M5.6 M13.9 M
Slightly volatile
Liabilities And Stockholders Equity2.4 M2.6 M8.2 M
Pretty Stable
Non Current Liabilities Total7.4 M3.8 M2.8 M
Slightly volatile
Other Stockholder Equity47.4 M45.2 M9.1 M
Slightly volatile
Total Liabilities9.1 M7.9 M3.6 M
Slightly volatile
Common Stock1.7 K1.8 K6.8 M
Pretty Stable
Short and Long Term Debt Total5.4 M5.2 M1.1 M
Slightly volatile
Property Plant And Equipment Net466 K644 K467.6 K
Pretty Stable
Capital Lease Obligations354.9 K604.9 K304.7 K
Slightly volatile
Property Plant And Equipment Gross444.3 K566.1 K653.7 K
Slightly volatile
Capital Stock1.5 K2.3 K1.2 K
Slightly volatile
Short Term Debt1.4 M1.3 M324 K
Slightly volatile
Long Term Debt2.4 M2.7 M2.9 M
Slightly volatile
Short Term Investments28 K31.5 K34.4 K
Slightly volatile
Short and Long Term Debt803.2 K903.6 K986.3 K
Slightly volatile

Biomotion Sciences Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Other Operating Expenses15.2 M14.5 M3.2 M
Slightly volatile
Total Operating Expenses15.2 M14.5 M3.2 M
Slightly volatile
Tax Provision17.6 KK22.4 K
Slightly volatile
Interest Income85590096.3 K
Slightly volatile
Depreciation And Amortization33.9 K22.5 K51 K
Slightly volatile
Interest Expense38.9 K46.8 K73.6 K
Slightly volatile
Selling General Administrative8.1 M7.7 M1.8 M
Slightly volatile
Research Development4.7 M6.7 M3.7 M
Slightly volatile
Reconciled Depreciation33.9 K22.5 K51 K
Slightly volatile
Income Tax Expense17.6 KK22.4 K
Slightly volatile
Minority Interest65 K68.4 K230.8 K
Slightly volatile
Cost Of Revenue20 K22.5 K24.6 K
Slightly volatile

Biomotion Sciences Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation35.5 K28.8 K41.8 K
Slightly volatile
Change To Operating Activities21.6 K24.3 K26.5 K
Slightly volatile
Total Cash From Financing Activities4.4 M4.6 M8.2 M
Pretty Stable
End Period Cash Flow1.1 M1.1 M2.8 M
Slightly volatile
Change To Netincome32 K36 K39.3 K
Slightly volatile
Change To Liabilities44 K49.5 K54 K
Slightly volatile
Begin Period Cash Flow5.3 M4.2 M8.4 M
Slightly volatile
Stock Based Compensation7.1 M6.7 M1.3 M
Slightly volatile
Issuance Of Capital Stock2.3 M3.5 M2.7 M
Pretty Stable

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Capex To Depreciation0.50.790.68
Pretty Stable
Cash Per Share0.160.170.3037
Slightly volatile
Income Quality1.010.580.5892
Slightly volatile
Current Ratio0.70.731.7847
Very volatile
Capex Per Share0.00330.00320.0014
Slightly volatile
Interest Debt Per Share0.690.660.148
Slightly volatile
Debt To Assets1.481.410.2864
Slightly volatile
Ebt Per Ebit0.821.180.8762
Slightly volatile
Quick Ratio0.70.731.7847
Very volatile
Net Income Per E B T0.780.90.9244
Pretty Stable
Cash Ratio0.370.391.6338
Pretty Stable
Free Cash Flow Operating Cash Flow Ratio1.11.151.0157
Slightly volatile
Debt Ratio1.481.410.2864
Slightly volatile

Biomotion Sciences Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap3.5 BB4.3 B
Slightly volatile
Enterprise Value3.5 BB4.3 B
Slightly volatile

Biomotion Fundamental Market Drivers

About Biomotion Sciences Financial Statements

Biomotion Sciences investors utilize fundamental indicators, such as revenue or net income, to predict how Biomotion Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Cost Of Revenue22.5 K20 K

Pair Trading with Biomotion Sciences

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Biomotion Sciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biomotion Sciences will appreciate offsetting losses from the drop in the long position's value.

Moving together with Biomotion Stock

  0.75DWTX Dogwood TherapeuticsPairCorr
  0.85EDIT Editas MedicinePairCorr

Moving against Biomotion Stock

  0.7IMMP Immutep Ltd ADRPairCorr
  0.62DSGN Design TherapeuticsPairCorr
  0.6ENGN enGene Holdings CommonPairCorr
  0.56KYTX Kyverna TherapeuticsPairCorr
  0.5563E ONWARD MEDICAL BVPairCorr
The ability to find closely correlated positions to Biomotion Sciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Biomotion Sciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Biomotion Sciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Biomotion Sciences Ordinary to buy it.
The correlation of Biomotion Sciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Biomotion Sciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Biomotion Sciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Biomotion Sciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Biomotion Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biomotion Sciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biomotion Sciences Ordinary Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biomotion Sciences Ordinary Stock:
Check out the analysis of Biomotion Sciences Correlation against competitors.
You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Will Biotechnology sector continue expanding? Could Biomotion diversify its offerings? Factors like these will boost the valuation of Biomotion Sciences. If investors know Biomotion will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Biomotion Sciences data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
349.09
Return On Assets
(0.78)
Return On Equity
(7.71)
The market value of Biomotion Sciences is measured differently than its book value, which is the value of Biomotion that is recorded on the company's balance sheet. Investors also form their own opinion of Biomotion Sciences' value that differs from its market value or its book value, called intrinsic value, which is Biomotion Sciences' true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Biomotion Sciences' market value can be influenced by many factors that don't directly affect Biomotion Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biomotion Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Biomotion Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Biomotion Sciences' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.